{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:35:02Z","timestamp":1789763702517,"version":"4.0.1"},"reference-count":154,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>\u03b2-blockers have found wide application in cardiology, neurology, psychiatry, anaesthesiology, and endocrinology. Due to the reduction in excessive reactivity of the peripheral sympathetic nervous system, they have been used in the treatment of symptoms of hyperthyroidism. Significant efficacy in alleviating neuro-psychiatric symptoms associated with hyperthyroidism is attributed to propranolol, while cardiac symptoms are alleviated by both non-selective and cardioselective \u03b2-blockers. The aim of our study is to collect and summarise the existing knowledge on the role of \u03b2-blockers in patients with hyperthyroidism, with particular emphasis on pregnant patients, the group with iatrogenic hyperthyroidism, and patients after amiodarone. Due to their favourable safety profile, they appear to be a beneficial supplementary therapy to the treatment of hyperthyroidism in pregnant patients. \u03b2-blockers are also used in the treatment of complications of hyperthyroidism after amiodarone administration. They may influence the therapeutic process of amiodarone-induced hyperthyroidism itself, as well as being a therapeutic alternative to amiodarone in a cardiovascular context. By alleviating the symptoms associated with high doses of L-thyroxine, which are used, e.g., in. patients with thyroid cancer, \u03b2-blockers may make it possible to maintain low TSH values.<\/jats:p>","DOI":"10.3390\/ijms26178322","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:31:12Z","timestamp":1756373472000},"page":"8322","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Therapeutic Potential of Propranolol and Other Beta-Blockers in Hyperthyroidism"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9208-9749","authenticated-orcid":false,"given":"Weronika","family":"Szybiak-Skora","sequence":"first","affiliation":[{"name":"University Clinical Hospital in Poznan, Poznan University of Medical Sciences, 60-355 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9773-1461","authenticated-orcid":false,"given":"Mi\u0142osz","family":"Miedziaszczyk","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Sza\u0142ek","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Biopharmacy, Poznan University of Medical Sciences, 60-806 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2386-4795","authenticated-orcid":false,"given":"Katarzyna","family":"Lacka","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-355 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"key":"ref_1","unstructured":"Farzam, K., and Jan, A. (2023). Beta blockers. StatPearls, StatPearls Publishing."},{"key":"ref_2","first-page":"S9","article-title":"Contemporary use of \u03b2-blockers: Clinical relevance of subclassification","volume":"30","author":"Poirier","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Perez, D.M. (2006). The Adrenergic Receptors in the 21st Century, Humana Press.","DOI":"10.1385\/1592599311"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e40495","DOI":"10.1097\/MD.0000000000040495","article-title":"The effects of methimazole combined with propranolol on heart rate, bone metabolism, and thyroid hormone levels in patients with hyperthyroidism: A systematic review and a meta-analysis of case-control studies","volume":"103","author":"Xie","year":"2024","journal-title":"Medicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10157-011-0494-1","article-title":"Convergence of major physiological stimuli for renin release on the Gs-alpha\/cyclic adenosine monophosphate signaling pathway","volume":"16","author":"Kim","year":"2012","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11940-019-0556-3","article-title":"Beta-Blockers for Migraine Prevention: A Review Article","volume":"21","author":"Danesh","year":"2019","journal-title":"Curr. Treat. Options Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jad.2024.09.068","article-title":"Beta-blockers for the treatment of anxiety disorders: A systematic review and meta-analysis","volume":"368","author":"Archer","year":"2025","journal-title":"J. Affect. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the","volume":"116","author":"Klein","year":"2007","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0002-9343(89)80614-X","article-title":"Graves\u2019 disease: An analysis of thyroid hormone levels and hyperthyroid signs and symptoms","volume":"87","author":"Trzepacz","year":"1989","journal-title":"Am. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2169\/internalmedicine.51.7302","article-title":"Short-term effects of beta-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves\u2019 disease","volume":"51","author":"Tagami","year":"2012","journal-title":"Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Wo\u0142owiec, \u0141., Grze\u015bk, G., Osiakl, J., Wijata, A., M\u0119dlewska, M., Gaborek, P., Banach, J., Wo\u0142owiec, A., and G\u0142owacka, M. (2023). Beta-blockers in cardiac arrhythmias-Clinical pharmacologist\u2019s point of view. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1043714"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Barrese, V., and Taglialatela, M. (2013). New advances in beta-blocker therapy in heart failure. Front. Physiol., 4.","DOI":"10.3389\/fphys.2013.00323"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ji, Y., Chen, S., Wang, Q., Xiang, B., Xu, Z., Zhong, L., Yang, K., Lu, G., and Qiu, L. (2018). Intolerable side effects during propranolol therapy for infantile hemangioma: Frequency, risk factors and management. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-22787-8"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.hlc.2018.03.017","article-title":"The Use of Intravenous Sotalol in Cardiac Arrhythmias","volume":"27","author":"Samanta","year":"2018","journal-title":"Heart Lung Circ."},{"key":"ref_16","unstructured":"(2025, August 01). LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK547852\/."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bu, J., Ding, R., Zhou, L., Chen, X., and Shen, E. (2022). Epidemiology of Psoriasis and Comorbid Diseases: A Narrative Review. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.880201"},{"key":"ref_18","first-page":"e934600","article-title":"BRASH Syndrome: A Case Report","volume":"23","author":"Siqueira","year":"2022","journal-title":"Am. J. Case Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00003495-199040010-00005","article-title":"Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension","volume":"40","author":"Buckley","year":"1990","journal-title":"Drugs"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: A review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.5665\/sleep.2122","article-title":"Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: A randomized controlled trial","volume":"35","author":"Scheer","year":"2012","journal-title":"Sleep"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1185\/03007990903533681","article-title":"Effects of beta-blockers on glucose and lipid metabolism","volume":"26","author":"Fonseca","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_23","first-page":"e8964","article-title":"Mechanisms of Beta-Blocker Induced Psoriasis, and Psoriasis De Novo at the Cellular Level","volume":"12","author":"Awad","year":"2020","journal-title":"Cureus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1503\/cmaj.081433","article-title":"Exacerbation of psoriasis with beta-blocker therapy","volume":"181","author":"Waqar","year":"2009","journal-title":"CMAJ"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1213\/ANE.0b013e3182025af7","article-title":"The safety of perioperative esmolol: A systematic review and meta-analysis of randomized controlled trials","volume":"112","author":"Yu","year":"2011","journal-title":"Anesth. Analg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0735-1097(84)80025-X","article-title":"Safety and efficacy of esmolol (ASL-8052: An ultrashort-acting beta-adrenergic blocking agent) for control of ventricular rate in supraventricular tachycardias","volume":"3","author":"Byrd","year":"1984","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","first-page":"28","article-title":"The effect of esmolol given during cardiopulmonary bypass","volume":"80","author":"Cork","year":"1995","journal-title":"Anesth. Analg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/emermed-2017-207065","article-title":"Outcomes of beta blocker use in cocaine-associated chest pain: A meta-analysis","volume":"35","author":"Pham","year":"2018","journal-title":"Emerg. Med. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/11631590-000000000-00000","article-title":"Clinical pharmacokinetics and therapeutic efficacy of esmolol","volume":"51","author":"Wiest","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s40265-018-0999-y","article-title":"A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension","volume":"78","author":"Cicero","year":"2018","journal-title":"Drugs"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/phrs.1998.0387","article-title":"Pharmacology of nebivolol","volume":"38","author":"Mangrella","year":"1998","journal-title":"Pharmacol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00003495-199754010-00015","article-title":"Carvedilol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders","volume":"54","author":"Dunn","year":"1997","journal-title":"Drugs"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2165\/00003495-199345020-00006","article-title":"Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy","volume":"45","author":"McTavish","year":"1993","journal-title":"Drugs"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.2174\/1381612827666210716162130","article-title":"Contraindications Differ Widely Among Beta Blockers and Ought to be Cited for an Individual Drug, Not for the Entire Class","volume":"27","year":"2021","journal-title":"Curr. Pharm. Des."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.clinthera.2009.03.007","article-title":"Nebivolol: A third-generation beta-blocker for hypertension","volume":"31","author":"Cheng","year":"2009","journal-title":"Clin. Ther."},{"key":"ref_36","first-page":"7","article-title":"Beta-blockers for heart failure: An evidence based review answering practical therapeutic questions","volume":"67","author":"Ong","year":"2012","journal-title":"Med. J. Malays."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00005344-200112003-00006","article-title":"Metabolic effects and safety profile of nebivolol","volume":"38","author":"Pessina","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1540-8159.2012.03410.x","article-title":"Management of patients with drug-induced atrioventricular block","volume":"35","author":"Osmonov","year":"2012","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/0003-4819-137-9-200211050-00035","article-title":"Cardioselective beta-blockers in patients with reactive airway disease: A meta-analysis","volume":"137","author":"Salpeter","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s00228-020-02937-6","article-title":"Population pharmacokinetic analysis of bisoprolol in type 2 diabetic patients with hypertension","volume":"76","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2174\/1570161119666210302152322","article-title":"By Discontinuing Beta-Blockers Before an Exercise Test, We may Precipitate a Rebound Phenomenon","volume":"19","author":"Koracevic","year":"2021","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/1060028013519591","article-title":"\u03b2-blockers: A review of their pharmacological and physiological diversity in hypertension","volume":"48","author":"Ripley","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"ref_43","first-page":"437","article-title":"The dose-related effects of bolus esmolol on heart rate and blood pressure following laryngoscopy and intubation","volume":"68","author":"Bensky","year":"2000","journal-title":"AANA J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/j.1552-4604.1986.tb02929.x","article-title":"Effects of esmolol on airway function in patients with asthma","volume":"26","author":"Sheppard","year":"1986","journal-title":"J. Clin. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5830\/CVJA-2015-030","article-title":"Management and outcome of topical beta-blocker-induced atrioventricular block","volume":"26","author":"Osmonov","year":"2015","journal-title":"Cardiovasc. J. Afr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1573403X09666131117174414","article-title":"Acute decompensated heart failure update","volume":"11","author":"Teerlink","year":"2015","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/emj.2006.036582","article-title":"Best evidence topic report. Beta-Blockers in cocaine induced acute coronary syndrome","volume":"23","author":"Sen","year":"2006","journal-title":"Emerg. Med. J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaip.2017.12.020","article-title":"Patients Taking \u03b2-Blockers Do Not Require Increased Doses of Epinephrine for Anaphylaxis","volume":"6","author":"White","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.yjmcc.2021.05.015","article-title":"Molecular determinants of pro-arrhythmia proclivity of d- and l-sotalol via a multi-scale modeling pipeline","volume":"158","author":"DeMarco","year":"2021","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/thy.1991.1.273","article-title":"Propranolol and thyroid hormone metabolism","volume":"1","author":"Wiersinga","year":"1991","journal-title":"Thyroid"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1210\/jcem-44-5-1002","article-title":"Plasma thyroxine, 3,3\u2019,5-triiodothyronine and 3,3\u2019,5\u2019-triiodothyronine during beta-adrenergic blockade in hyperthyroidism","volume":"44","author":"Verhoeven","year":"1977","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_52","first-page":"e34474","article-title":"Benefit and Preference of Propranolol Over Metoprolol in Thyrotoxicosis-Induced Atrial Fibrillation: A Case Report and Review of Literature","volume":"15","author":"Obi","year":"2023","journal-title":"Cureus"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(03)14073-1","article-title":"Hyperthyroidism","volume":"362","author":"Cooper","year":"2003","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/jama.2023.19052","article-title":"Hyperthyroidism: A Review","volume":"330","author":"Lee","year":"2023","journal-title":"JAMA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s40618-020-01479-z","article-title":"Change in newly diagnosed Graves\u2019 disease phenotype between the twentieth and the twenty-first centuries: Meta-analysis and meta-regression","volume":"44","author":"Ippolito","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1530\/eje.1.02210","article-title":"The Danish investigation on iodine intake and thyroid disease, DanThyr: Status and perspectives","volume":"155","author":"Laurberg","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Cyna, W., Wojciechowska, A., Szybiak-Skora, W., and Lacka, K. (2024). The Impact of Environmental Factors on the Development of Autoimmune Thyroiditis-Review. Biomedicines, 12.","DOI":"10.3390\/biomedicines12081788"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.2001.01381.x","article-title":"Association between lithium use and thyrotoxicosis caused by silent thyroiditis","volume":"55","author":"Miller","year":"2001","journal-title":"Clin. Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"R91","DOI":"10.1530\/EJE-14-0198","article-title":"Endocrine side-effects of anti-cancer drugs: Thyroid effects of tyrosine kinase inhibitors","volume":"171","author":"Illouz","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nrendo.2009.225","article-title":"Effects of amiodarone therapy on thyroid function","volume":"6","author":"Dahl","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s12022-023-09789-7","article-title":"Neoplasms in Struma Ovarii: A Review","volume":"34","author":"Sande","year":"2023","journal-title":"Endocr. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/jcem-65-2-359","article-title":"Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves\u2019 disease despite similar serum total T4 levels","volume":"65","author":"Shigemasa","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1530\/EJE-13-0533","article-title":"Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: A population-based study","volume":"169","author":"Carle","year":"2013","journal-title":"Eur. J. Endocrinol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.emc.2013.12.001","article-title":"Hyperthyroidism and Thyrotoxicosis","volume":"32","author":"Devereaux","year":"2014","journal-title":"Emerg. Med. Clin. N. Am."},{"key":"ref_66","first-page":"206","article-title":"Classification and etiology of hyperthyroidism","volume":"36","author":"Fraczek","year":"2014","journal-title":"Pol. Merkur. Lek."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1210\/jc.2009-2495","article-title":"Older subjects with hyperthyroidism present with a paucity of symptoms and signs: A large cross-sectional study","volume":"95","author":"Boelaert","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_68","first-page":"619","article-title":"Neurologic complications of thyroid dysfunction","volume":"19","author":"Kudrjavcev","year":"1978","journal-title":"Adv. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Szeleszczuk, \u0141., and Fr\u0105czkowski, D. (2022). Propranolol versus Other Selected Drugs in the Treatment of Various Types of Anxiety or Stress, with Particular Reference to Stage Fright and Post-Traumatic Stress Disorder. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231710099"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0269881115612236","article-title":"Propranolol for the treatment of anxiety disorders: Systematic review and meta-analysis","volume":"30","author":"Steenen","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/S0140-6736(65)92340-8","article-title":"Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state","volume":"2","author":"Turner","year":"1965","journal-title":"Lancet"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.120111","article-title":"Propranolol\u2019s effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: A meta-analysis","volume":"38","author":"Lonergan","year":"2013","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_73","first-page":"760","article-title":"Cognitive functions and mood during chronic thyrotropin-suppressive therapy with L-thyroxine in patients with differentiated thyroid carcinoma","volume":"35","author":"Jaracz","year":"2012","journal-title":"J. Endocrinol. Investig."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/000992289103000706","article-title":"The effect of beta blockade on stress-induced cognitive dysfunction in adolescents","volume":"30","author":"Faigel","year":"1991","journal-title":"Clin. Pediatr."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Cojocariu, S.A., Ma\u0219taleru, A., Sasc\u0103u, R.A., St\u0103tescu, C., Mitu, F., and Leon-Constantin, M.M. (2021). Neuropsychiatric Consequences of Lipophilic Beta-Blockers. Medicina, 57.","DOI":"10.3390\/medicina57020155"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.27121","article-title":"Tremor Task Force of the International Parkinson and Movement Disorder Society. Consensus Statement on the classification of tremors. From the task force on tremor of the International Parkinson and Movement Disorder Society","volume":"33","author":"Bhatia","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJMcp1707928","article-title":"Essential Tremor","volume":"378","author":"Haubenberger","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/WNL.34.8.1077","article-title":"Propranolol therapy for essential tremor of the head","volume":"34","author":"Koller","year":"1984","journal-title":"Neurology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1474-4422(10)70322-7","article-title":"Treatment of patients with essential tremor","volume":"10","author":"Deuschl","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3121\/cmr.2009.816","article-title":"Thyrotoxic periodic paralysis: A case report and literature review","volume":"7","author":"Barahona","year":"2009","journal-title":"Clin. Med. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/00007611-200093100-00010","article-title":"Thyrotoxic periodic paralysis","volume":"93","author":"Magsino","year":"2000","journal-title":"South Med. J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1507\/endocrj.K07-126","article-title":"Toxic thyroid adenoma presenting as hypokalemic periodic paralysis","volume":"54","author":"Tagami","year":"2007","journal-title":"Endocr. J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1161\/hc5001.100621","article-title":"Impact of hyperthyroidism and its correction on vascular reactivity in humans","volume":"104","author":"Napoli","year":"2001","journal-title":"Circulation"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/heart.84.4.455","article-title":"Thyroid disease and the heart","volume":"84","author":"Toft","year":"2000","journal-title":"Heart"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/clc.4960230605","article-title":"Hyperthyroid heart disease","volume":"23","author":"Fadel","year":"2000","journal-title":"Clin. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"60","DOI":"10.14797\/mdcj-13-2-60","article-title":"Hyperthyroidism and the Heart","volume":"13","author":"Osuna","year":"2017","journal-title":"Methodist. Debakey Cardiovasc. J."},{"key":"ref_87","first-page":"e21213","article-title":"Cardiovascular Involvement in Thyrotoxicosis Resulting in Heart Failure: The Risk Factors and Hemodynamic Implications","volume":"14","author":"Raguthu","year":"2022","journal-title":"Cureus"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"292574","DOI":"10.1155\/2015\/292574","article-title":"The Role of the Multiple Hormonal Dysregulation in the Onset of \u201cAnemia of Aging\u201d: Focus on Testosterone, IGF-1, and Thyroid Hormones","volume":"2015","author":"Maggio","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10741-008-9125-7","article-title":"Cardiac hypertrophy and thyroid hormone signaling","volume":"15","author":"Dillmann","year":"2010","journal-title":"Heart Fail. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2265.2011.03981.x","article-title":"Hyperthyroidism-induced left ventricular diastolic dysfunction: Implication in hyperthyroidism-related heart failure","volume":"74","author":"Yue","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2011-1978","article-title":"Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk","volume":"97","author":"Nanchen","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/hrt.2006.100628","article-title":"Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism","volume":"93","author":"Siu","year":"2007","journal-title":"Heart"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3949\/ccjm.70.1.57","article-title":"Thyrotoxicosis and the cardiovascular system: Subtle but serious effects","volume":"70","author":"Roffi","year":"2003","journal-title":"Cleve Clin. J. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"104274","DOI":"10.1016\/j.phrs.2019.104274","article-title":"Antiarrhythmic mechanisms of beta blocker therapy","volume":"146","author":"Grandi","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/1389557515666151016125948","article-title":"Beta-Blockers: Current State of Knowledge and Perspectives","volume":"16","author":"Ogrodowczyk","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0895-7061(99)00005-9","article-title":"Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects","volume":"12","author":"Blumenfeld","year":"1999","journal-title":"Am. J. Hypertens."},{"key":"ref_97","first-page":"4224","article-title":"Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine","volume":"81","author":"Biondi","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_98","first-page":"179","article-title":"The role of selective beta-1 blocker in the preoperative preparation of thyrotoxicosis: A comparative study with propranalol","volume":"75","author":"Vickers","year":"1990","journal-title":"Int. Surg."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/eje.0.1500757","article-title":"Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: Acute effects of beta1-adrenergic blockade","volume":"150","author":"Palmieri","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.jaip.2022.04.002","article-title":"Hormonal Effects on Asthma, Rhinitis, and Eczema","volume":"10","author":"Chiarella","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Wang, X., Huang, Y., Li, X., He, Y., and Liu, X. (2023). The associations between asthma and common comorbidities: A comprehensive Mendelian randomization study. Front. Med., 10.","DOI":"10.3389\/fmed.2023.1251827"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.eprac.2021.02.011","article-title":"Characteristics and Risk Factors of Pulmonary Hypertension in Patients With Hyperthyroidism","volume":"27","author":"Song","year":"2021","journal-title":"Endocr. Pract."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"106974","DOI":"10.1016\/j.vph.2022.106974","article-title":"Beta-blockers in pulmonary arterial hypertension: Time for a second thought?","volume":"144","author":"Badagliacca","year":"2022","journal-title":"Vascul. Pharmacol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"H1004","DOI":"10.1152\/ajpheart.00202.2016","article-title":"Right ventricular end-diastolic stiffness heralds right ventricular failure in monocrotaline-induced pulmonary hypertension","volume":"311","author":"Alaa","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/1440-1681.12898","article-title":"Diastolic dysfunction in pulmonary artery hypertension: Creatine kinase and the potential therapeutic benefit of beta-blockers","volume":"45","author":"Fowler","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_106","first-page":"17","article-title":"Cancer statistics. 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid Cancer: A Review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"ref_108","first-page":"143","article-title":"A study of thyroglobulin concentration in the thyroid and serum of patients with different thyroid disorders","volume":"50","author":"Czarnywojtek","year":"2002","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Lacka, K., Maciejewski, A., Tyburski, P., Manuszewska-Jopek, E., Majewski, P., and Wi\u0119ckowska, B. (2025). Rationale for Testing TP53 Mutations in Thyroid Cancer-Original Data and Meta-Analysis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26031035"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/thy.2020.0272","article-title":"Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients","volume":"31","author":"Grani","year":"2021","journal-title":"Thyroid"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"ref_113","first-page":"34","article-title":"Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update","volume":"69","author":"Dedecjus","year":"2018","journal-title":"Endokrynol. Pol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/thy.2009.0311","article-title":"Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer","volume":"20","author":"Biondi","year":"2010","journal-title":"Thyroid"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5603\/EP.a2022.0028","article-title":"Diagnosis and treatment of thyroid cancer in adult patients\u2014Recommendations of Polish Scientific Societies and the National Oncological Strategy. 2022 Update","volume":"73","author":"Dedecjus","year":"2022","journal-title":"Endokrynol. Pol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/thy.1998.8.803","article-title":"Subclinical thyroid disease in the elderly","volume":"8","author":"Samuels","year":"1998","journal-title":"Thyroid"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.295.9.1033","article-title":"Thyroid status, cardiovascular risk, and mortality in older adults","volume":"295","author":"Cappola","year":"2006","journal-title":"JAMA"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-08-0110","article-title":"Subclinical thyroid dysfunction and mortality: An estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies","volume":"159","author":"Haentjens","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1677\/erc.0.0110345","article-title":"Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma","volume":"11","author":"Barrios","year":"2004","journal-title":"Endocr.-Relat. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1530\/eje.0.1500655","article-title":"Effects of TSH-suppressive therapy on cardiac morphology and function: Beneficial effects of the addition of beta-blockade on diastolic dysfunction","volume":"150","author":"Gullu","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"ref_122","first-page":"2222","article-title":"Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: Beneficial effect of beta-blockade","volume":"80","author":"Fazio","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1089\/thy.1998.8.859","article-title":"Thyroid hyperfunction during pregnancy","volume":"8","author":"Glinoer","year":"1998","journal-title":"Thyroid"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ecl.2019.05.002","article-title":"Hyperthyroidism and Pregnancy","volume":"48","author":"Kobaly","year":"2019","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/BF03348950","article-title":"Serum levels of intact human chorionic gonadotropin (HCG) and its free alpha and beta subunits, in relation to maternal thyroid stimulation during normal pregnancy","volume":"16","author":"Glinoer","year":"1993","journal-title":"J. Endocrinol. Investig."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1210\/jcem-55-1-108","article-title":"Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves\u2019 disease","volume":"55","author":"Amino","year":"1982","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9378(13)70286-2","article-title":"A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy","volume":"170","author":"Wing","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-14-0135","article-title":"Therapy of endocrine disease: Antithyroid drug use in early pregnancy and birth defects: Time windows of relative safety and high risk?","volume":"171","author":"Laurberg","year":"2014","journal-title":"Eur. J. Endocrinol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: A Danish nationwide study","volume":"98","author":"Andersen","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0022-3476(75)80236-8","article-title":"Propranolol administration during pregnancy: Effects on the fetus","volume":"86","author":"Gladstone","year":"1975","journal-title":"J. Pediatr."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0022-3476(77)81048-2","article-title":"Effects on the neonate of propranolol administered during pregnancy","volume":"91","author":"Habib","year":"1977","journal-title":"J. Pediatr."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0002-9378(79)90436-8","article-title":"Long-term propranolol therapy in pregnancy: Maternal and fetal outcome","volume":"135","author":"Pruyn","year":"1979","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00404-002-0461-x","article-title":"Maternal arrhythmias during pregnancy","volume":"269","author":"Ferrero","year":"2004","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/thy.1999.9.647","article-title":"Hyperthyroidism in pregnancy: Diagnosis and treatment","volume":"9","author":"Masiukiewicz","year":"1999","journal-title":"Thyroid"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1253\/circj.CJ-22-0647","article-title":"\u03b1\/\u03b2- and \u03b2-Blocker Exposure in Pregnancy and the Risk of Neonatal Hypoglycemia and Small for Gestational Age","volume":"87","author":"Kubota","year":"2023","journal-title":"Circ. J."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00016349109007160","article-title":"Treatment of hyperthyroidism in pregnancy","volume":"70","author":"Sherif","year":"1991","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000300984","article-title":"Antihypertensive treatment with the adrenergic beta-receptor blocker metoprolol during pregnancy","volume":"9","year":"1978","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_138","first-page":"431","article-title":"Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension","volume":"1","author":"Rubin","year":"1983","journal-title":"Lancet"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11906-023-01234-8","article-title":"Beta-Blockers in Pregnancy: Clinical Update","volume":"25","author":"Katsi","year":"2023","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/bcp.14561","article-title":"Risk of congenital malformations in offspring of women using \u03b2-blockers during early pregnancy: An updated meta-analysis of observational studies","volume":"87","author":"Wu","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"132234","DOI":"10.1016\/j.ijcard.2024.132234","article-title":"Perinatal outcomes after in-utero exposure to beta-blockers in women with heart disease: Data from the ESC EORP registry of pregnancy and cardiac disease (ROPAC)","volume":"410","author":"Ramlakhan","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"ref_142","first-page":"e44043","article-title":"Beta-Blockers and Their Current Role in Maternal and Neonatal Health: A Narrative Review of the Literature","volume":"15","author":"Martinez","year":"2023","journal-title":"Cureus"},{"key":"ref_143","first-page":"462","article-title":"Optimization of antibiotic therapy in pregnancy\u2014Clinical implications","volume":"83","author":"Tomczak","year":"2012","journal-title":"Ginekol. Pol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin. Perinatol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1540-8167.1992.tb00972.x","article-title":"Amiodarone: Pharmacology, clinical actions and relationships between them","volume":"3","author":"Nattel","year":"1992","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/105072501300176471","article-title":"The various effects of amiodarone on thyroid function","volume":"11","author":"Bogazzi","year":"2001","journal-title":"Thyroid"},{"key":"ref_147","first-page":"240","article-title":"The effects of amiodarone on the thyroid","volume":"22","author":"Martino","year":"2001","journal-title":"Endocr. Rev."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2265.2008.03350.x","article-title":"Benzofuran derivatives and the thyroid","volume":"70","author":"Han","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2265.1987.tb00781.x","article-title":"Amiodarone iodine-induced hypothyroidism: Risk factors and follow-up in 28 cases","volume":"26","author":"Martino","year":"1987","journal-title":"Clin. Endocrinol."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jc.2002-021874","article-title":"Treatment of type II amiodarone-induced thyrotoxicosis by either iopanoic acid or glucocorticoids: A prospective, randomized study","volume":"88","author":"Bogazzi","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_151","first-page":"10.4045","article-title":"Amiodarone-induced thyrotoxicosis","volume":"141","author":"Anfinsen","year":"2021","journal-title":"Tidsskr. Nor. Laegeforen."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2042018811398516","article-title":"Management of amiodarone-related thyroid problems","volume":"2","author":"Narayana","year":"2011","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ando.2020.04.009","article-title":"Amiodarone-induced thyrotoxicosis","volume":"82","author":"Schubert","year":"2021","journal-title":"Ann. Endocrinol."},{"key":"ref_154","unstructured":"Feingold, K.R., Ahmed, S.F., Anawalt, B., Blackman, M.R., Boyce, A., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., and Dungan, K. (2022). Amiodarone induced thyrotoxicosis. Endotext, MDText.com, Inc."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8322\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:34:05Z","timestamp":1760034845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/17\/8322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":154,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["ijms26178322"],"URL":"https:\/\/doi.org\/10.3390\/ijms26178322","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]}}}